 | 5GI | Name: | ~{N}-[(2~{S})-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]propan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide | Formula: | C22 H25 F N4 O5 | SMILES: | Cc1onc(c1)C(=O)N[CH](Cc2ccc(F)cc2)C(=O)N[CH](C[CH]3CCCNC3=O)C=O | InChi: | InChI=1S/C22H25FN4O5/c1-13-9-19(27-32-13)22(31)26-18(10-14-4-6-16(23)7-5-14)21(30)25-17(12-28)11-15-3-2-8-24-20(15)29/h4-7,9,12,15,17-18H,2-3,8,10-11H2,1H3,(H,24,29)(H,25,30)(H,26,31)/t15-,17-,18-/m0/s1 | Definition date: | 2016-08-25 | Last modified: | 2024-09-27 | Release date: | 2017-05-31 | Identifier: | ~{N}-[(2~{S})-3-(4-fluorophenyl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]amino]propan-2-yl]-5-methyl-1,2-oxazole-3-carboxamide |
|
 | QUJ | Name: | 8-azanyl-4-(2-methylpropoxy)quinoline-2-carboxylic acid | Formula: | C14 H16 N2 O3 | SMILES: | CC(C)COc1cc(nc2c(N)cccc12)C(O)=O | InChi: | InChI=1S/C14H16N2O3/c1-8(2)7-19-12-6-11(14(17)18)16-13-9(12)4-3-5-10(13)15/h3-6,8H,7,15H2,1-2H3,(H,17,18) | Definition date: | 2016-05-24 | Last modified: | 2024-09-27 | Release date: | 2017-03-01 | Identifier: | 8-azanyl-4-(2-methylpropoxy)quinoline-2-carboxylic acid |
|
 | TP2 | Name: | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | Formula: | C14 H20 N2 O3 S2 | SMILES: | O=C(NCCS)C2N(S(=O)(=O)c1ccc(cc1)C)CCC2 | InChi: | InChI=1S/C14H20N2O3S2/c1-11-4-6-12(7-5-11)21(18,19)16-9-2-3-13(16)14(17)15-8-10-20/h4-7,13,20H,2-3,8-10H2,1H3,(H,15,17)/t13-/m1/s1 | Definition date: | 2000-06-13 | Last modified: | 2024-09-27 | Identifier: | 1-[(4-methylphenyl)sulfonyl]-N-(2-sulfanylethyl)-D-prolinamide |
|
 | W2C | Name: | (2S,4S)-N-[(2S)-1-azanylidene-3-[4-(4-cyanophenyl)phenyl]propan-2-yl]-4-oxidanyl-piperidine-2-carboxamide | Formula: | C22 H24 N4 O2 | SMILES: | O=C(NC(C=[N@H])Cc2ccc(c1ccc(C#N)cc1)cc2)C3NCCC(O)C3 | InChi: | InChI=1S/C22H24N4O2/c23-13-16-3-7-18(8-4-16)17-5-1-15(2-6-17)11-19(14-24)26-22(28)21-12-20(27)9-10-25-21/h1-8,14,19-21,24-25,27H,9-12H2,(H,26,28)/b24-14+/t19-,20-,21-/m0/s1 | Definition date: | 2013-10-31 | Last modified: | 2024-09-27 | Release date: | 2014-03-19 | Identifier: | (2S,4S)-N-[(2S,3E)-1-(4'-cyanobiphenyl-4-yl)-3-iminopropan-2-yl]-4-hydroxypiperidine-2-carboxamide |
|
 | W48 | Name: | (1S,2S)-2-[(N-{[(3-chlorophenyl)methoxy]carbonyl}-3-cyclohexyl-L-alanyl)amino]-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]propane-1-sulfonic acid | Formula: | C24 H32 Cl N3 O8 S | SMILES: | O=C1NC=CC1CC(NC(=O)C(CC1CCCCC1)NC(=O)OCc1cccc(Cl)c1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C24H32ClN3O8S/c25-18-8-4-7-16(11-18)14-36-24(32)28-19(12-15-5-2-1-3-6-15)22(30)27-20(23(31)37(33,34)35)13-17-9-10-26-21(17)29/h4,7-11,15,17,19-20,23,31H,1-3,5-6,12-14H2,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35)/t17-,19-,20-,23-/m0/s1 | Definition date: | 2022-01-19 | Last modified: | 2024-09-27 | Release date: | 2022-05-04 | Identifier: | (1S,2S)-2-[(N-{[(3-chlorophenyl)methoxy]carbonyl}-3-cyclohexyl-L-alanyl)amino]-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]propane-1-sulfonic acid |
|
 | MSE | Name: | SELENOMETHIONINE | Formula: | C5 H11 N O2 Se | SMILES: | O=C(O)C(N)CC[Se]C | InChi: | InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-4-(methylselanyl)butanoic acid |
|
 | QUK | Name: | 8-azanyl-4-(3-azanylpropoxy)quinoline-2-carboxylic acid | Formula: | C13 H15 N3 O3 | SMILES: | NCCCOc1cc(nc2c(N)cccc12)C(O)=O | InChi: | InChI=1S/C13H15N3O3/c14-5-2-6-19-11-7-10(13(17)18)16-12-8(11)3-1-4-9(12)15/h1,3-4,7H,2,5-6,14-15H2,(H,17,18) | Definition date: | 2016-05-24 | Last modified: | 2024-09-27 | Release date: | 2017-03-01 | Identifier: | 8-azanyl-4-(3-azanylpropoxy)quinoline-2-carboxylic acid |
|
 | R8F | Name: | (1R,5S)-8-(9H-purin-6-yl)-2-oxa-8-azabicyclo[3.3.1]nona-3,6-diene-4,6-dicarbaldehyde | Formula: | C14 H11 N5 O3 | SMILES: | O=CC1=CO[CH]2C[CH]1C(=CN2c3ncnc4nc[nH]c34)C=O | InChi: | InChI=1S/C14H11N5O3/c20-3-8-2-19(11-1-10(8)9(4-21)5-22-11)14-12-13(16-6-15-12)17-7-18-14/h2-7,10-11H,1H2,(H,15,16,17,18)/t10-,11+/m0/s1 | Synonyms: | (1~{R},5~{S})-8-(7~{H}-purin-6-yl)-2-oxa-8-azabicyclo[3.3.1]nona-3,6-diene-4,6-dicarbaldehyde | Definition date: | 2022-11-25 | Last modified: | 2024-09-27 | Release date: | 2023-11-29 | Identifier: | (1~{R},5~{S})-8-(7~{H}-purin-6-yl)-2-oxa-8-azabicyclo[3.3.1]nona-3,6-diene-4,6-dicarbaldehyde |
|
 | QH0 | Name: | (phenylmethyl) N-[(2S)-4-methyl-1-[[(2S)-4-nitro-1-[(3R)-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]carbamate | Formula: | C22 H32 N4 O6 | SMILES: | CC(C)C[CH](NC(=O)OCc1ccccc1)C(=O)N[CH](CC[N+]([O-])=O)C[CH]2CCNC2=O | InChi: | InChI=1S/C22H32N4O6/c1-15(2)12-19(25-22(29)32-14-16-6-4-3-5-7-16)21(28)24-18(9-11-26(30)31)13-17-8-10-23-20(17)27/h3-7,15,17-19H,8-14H2,1-2H3,(H,23,27)(H,24,28)(H,25,29)/t17-,18-,19+/m1/s1 | Definition date: | 2022-10-31 | Last modified: | 2024-09-27 | Release date: | 2023-11-08 | Identifier: | (phenylmethyl) ~{N}-[(2~{S})-4-methyl-1-[[(2~{S})-4-nitro-1-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]butan-2-yl]amino]-1-oxidanylidene-pentan-2-yl]carbamate |
|
 | QUM | Name: | QUINACRINE MUSTARD | Formula: | C23 H28 Cl3 N3 O | SMILES: | ClCCN(CCCl)CCCC(/N=C2c1c(ccc(OC)c1)Nc3c2ccc(Cl)c3)C | InChi: | InChI=1S/C23H28Cl3N3O/c1-16(4-3-11-29(12-9-24)13-10-25)27-23-19-7-5-17(26)14-22(19)28-21-8-6-18(30-2)15-20(21)23/h5-8,14-16H,3-4,9-13H2,1-2H3,(H,27,28)/t16-/m0/s1 | Synonyms: | N-{(1S)-4-[BIS(2-CHLOROETHYL)AMINO]-1-METHYLBUTYL}-N-(6-CHLORO-2-METHOXY-9-ACRIDINYL)AMINE | Definition date: | 2002-04-04 | Last modified: | 2024-09-27 | Identifier: | (4S)-N~1~,N~1~-bis(2-chloroethyl)-N~4~-[(9Z)-6-chloro-2-methoxyacridin-9(10H)-ylidene]pentane-1,4-diamine |
|
 | TB2 | Name: | (4-tert-butylphenyl)acetaldehyde | Formula: | C12 H16 O | SMILES: | O=CCc1ccc(cc1)C(C)(C)C | InChi: | InChI=1S/C12H16O/c1-12(2,3)11-6-4-10(5-7-11)8-9-13/h4-7,9H,8H2,1-3H3 | Definition date: | 2011-03-16 | Last modified: | 2024-09-27 | Identifier: | (4-tert-butylphenyl)acetaldehyde |
|
 | Q1N | Name: | (2~{R})-~{N}-(2-azanylideneethyl)-2-[2-(3-methyl-1,2-oxazol-5-yl)ethanoylamino]-3-(4-pyridin-2-ylpiperazin-1-yl)sulfonyl-propanamide | Formula: | C20 H27 N7 O5 S | SMILES: | Cc1cc(CC(=O)N[CH](C[S](=O)(=O)N2CCN(CC2)c3ccccn3)C(=O)NCC=N)on1 | InChi: | InChI=1S/C20H27N7O5S/c1-15-12-16(32-25-15)13-19(28)24-17(20(29)23-7-5-21)14-33(30,31)27-10-8-26(9-11-27)18-4-2-3-6-22-18/h2-6,12,17,21H,7-11,13-14H2,1H3,(H,23,29)(H,24,28)/b21-5-/t17-/m0/s1 | Definition date: | 2020-05-05 | Last modified: | 2024-09-27 | Release date: | 2021-05-12 | Identifier: | (2~{R})-~{N}-(2-azanylideneethyl)-2-[2-(3-methyl-1,2-oxazol-5-yl)ethanoylamino]-3-(4-pyridin-2-ylpiperazin-1-yl)sulfonyl-propanamide |
|
 | 5GM | Name: | (4S)-2,4-dimethyl-L-norleucine | Formula: | C8 H17 N O2 | SMILES: | NC(C(=O)O)(CC(C)CC)C | InChi: | InChI=1S/C8H17NO2/c1-4-6(2)5-8(3,9)7(10)11/h6H,4-5,9H2,1-3H3,(H,10,11)/t6-,8-/m0/s1 | Definition date: | 2015-09-24 | Last modified: | 2024-09-27 | Release date: | 2016-07-20 | Identifier: | (4S)-2,4-dimethyl-L-norleucine |
|
 | R8H | Name: | (2~{R})-5-oxidanylidene-~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]-1-(phenylmethyl)pyrrolidine-2-carboxamide | Formula: | C28 H30 N4 O4 | SMILES: | O[CH]([CH](Cc1ccccc1)NC(=O)[CH]2CCC(=O)N2Cc3ccccc3)C(=O)NCc4ccccn4 | InChi: | InChI=1S/C28H30N4O4/c33-25-15-14-24(32(25)19-21-11-5-2-6-12-21)27(35)31-23(17-20-9-3-1-4-10-20)26(34)28(36)30-18-22-13-7-8-16-29-22/h1-13,16,23-24,26,34H,14-15,17-19H2,(H,30,36)(H,31,35)/t23-,24-,26+/m1/s1 | Definition date: | 2020-09-18 | Last modified: | 2024-09-27 | Release date: | 2021-07-07 | Identifier: | (2~{R})-5-oxidanylidene-~{N}-[(2~{R},3~{S})-3-oxidanyl-4-oxidanylidene-1-phenyl-4-(pyridin-2-ylmethylamino)butan-2-yl]-1-(phenylmethyl)pyrrolidine-2-carboxamide |
|
 | N6U | Name: | ~{N}-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)ethanesulfonamide | Formula: | C9 H11 N3 O2 S | SMILES: | CC[S](=O)(=O)Nc1ccnc2[nH]ccc12 | InChi: | InChI=1S/C9H11N3O2S/c1-2-15(13,14)12-8-4-6-11-9-7(8)3-5-10-9/h3-6H,2H2,1H3,(H2,10,11,12) | Definition date: | 2022-08-12 | Last modified: | 2024-09-27 | Release date: | 2022-09-28 | Identifier: | ~{N}-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)ethanesulfonamide |
|
 | MSI | Name: | 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE | Formula: | C20 H20 N2 O5 S | SMILES: | O=S(=O)(c2cc1C(=O)C(=O)N(c1cc2)C)N4C(COc3ccccc3)CCC4 | InChi: | InChI=1S/C20H20N2O5S/c1-21-18-10-9-16(12-17(18)19(23)20(21)24)28(25,26)22-11-5-6-14(22)13-27-15-7-3-2-4-8-15/h2-4,7-10,12,14H,5-6,11,13H2,1H3/t14-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 1-methyl-5-{[(2S)-2-(phenoxymethyl)pyrrolidin-1-yl]sulfonyl}-1H-indole-2,3-dione |
|
 | 5GP | Name: | GUANOSINE-5'-MONOPHOSPHATE | Formula: | C10 H14 N5 O8 P | SMILES: | O=C1c2ncn(c2N=C(N)N1)C3OC(C(O)C3O)COP(=O)(O)O | InChi: | InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 5'-guanylic acid |
|
 | QH4 | Name: | {(2S)-4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-propanoylpiperazin-2-yl}acetonitrile | Formula: | C32 H39 N7 O2 | SMILES: | C(C#N)C1CN(CCN1C(=O)CC)c2nc(nc3CN(CCc23)c4c5c(ccc4)cccc5)OCC6CCCN6C | InChi: | InChI=1S/C32H39N7O2/c1-3-30(40)39-19-18-38(20-24(39)13-15-33)31-27-14-17-37(29-12-6-9-23-8-4-5-11-26(23)29)21-28(27)34-32(35-31)41-22-25-10-7-16-36(25)2/h4-6,8-9,11-12,24-25H,3,7,10,13-14,16-22H2,1-2H3/t24-,25-/m0/s1 | Definition date: | 2019-11-01 | Last modified: | 2024-09-27 | Release date: | 2020-04-22 | Identifier: | {(2S)-4-[2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-propanoylpiperazin-2-yl}acetonitrile |
|
 | UU4 | Name: | (2S)-2-amino-4-(L-serylamino)butanoic acid | Formula: | C7 H15 N3 O4 | SMILES: | O=C(NCCC(C(=O)O)N)C(N)CO | InChi: | InChI=1S/C7H15N3O4/c8-4(7(13)14)1-2-10-6(12)5(9)3-11/h4-5,11H,1-3,8-9H2,(H,10,12)(H,13,14)/t4-,5-/m0/s1 | Definition date: | 2012-11-14 | Last modified: | 2024-09-27 | Release date: | 2013-08-21 | Identifier: | (2S)-2-amino-4-(L-serylamino)butanoic acid |
|
 | R8L | Name: | (E)-3-[2-[(2R,3S)-3-[(1R)-1-aminocarbonyloxypropyl]oxiran-2-yl]phenyl]prop-2-enoic acid | Formula: | C15 H17 N O5 | SMILES: | CC[CH](OC(N)=O)[CH]1O[CH]1c2ccccc2C=CC(O)=O | InChi: | InChI=1S/C15H17NO5/c1-2-11(20-15(16)19)14-13(21-14)10-6-4-3-5-9(10)7-8-12(17)18/h3-8,11,13-14H,2H2,1H3,(H2,16,19)(H,17,18)/b8-7+/t11-,13-,14+/m1/s1 | Definition date: | 2023-09-05 | Last modified: | 2024-09-27 | Release date: | 2024-06-12 | Identifier: | (~{E})-3-[2-[(2~{R},3~{S})-3-[(1~{R})-1-aminocarbonyloxypropyl]oxiran-2-yl]phenyl]prop-2-enoic acid |
|
 | 1JM | Name: | 4-carboxy-N-methyl-D-phenylalanine | Formula: | C11 H13 N O4 | SMILES: | O=C(O)C(NC)Cc1ccc(cc1)C(=O)O | InChi: | InChI=1S/C11H13NO4/c1-12-9(11(15)16)6-7-2-4-8(5-3-7)10(13)14/h2-5,9,12H,6H2,1H3,(H,13,14)(H,15,16)/t9-/m1/s1 | Definition date: | 2013-02-15 | Last modified: | 2024-09-27 | Release date: | 2013-11-06 | Identifier: | 4-carboxy-N-methyl-D-phenylalanine |
|
 | UU5 | Name: | (2S)-2-amino-4-[(oxoacetyl)amino]butanoic acid | Formula: | C6 H10 N2 O4 | SMILES: | O=C(O)C(N)CCNC(=O)C=O | InChi: | InChI=1S/C6H10N2O4/c7-4(6(11)12)1-2-8-5(10)3-9/h3-4H,1-2,7H2,(H,8,10)(H,11,12)/t4-/m0/s1 | Definition date: | 2012-11-12 | Last modified: | 2024-09-27 | Release date: | 2013-08-21 | Identifier: | (2S)-2-amino-4-[(oxoacetyl)amino]butanoic acid |
|
 | N6Z | Name: | ~{N}-[3-[6-azanyl-5-[2-[methyl(propanoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoranyl-2-methyl-phenyl]-4-cyclopropyl-2-fluoranyl-benzamide | Formula: | C27 H29 F2 N5 O3 | SMILES: | CCC(=O)N(C)CCOc1c(N)ncnc1c2cc(F)cc(NC(=O)c3ccc(cc3F)C4CC4)c2C | InChi: | InChI=1S/C27H29F2N5O3/c1-4-23(35)34(3)9-10-37-25-24(31-14-32-26(25)30)20-12-18(28)13-22(15(20)2)33-27(36)19-8-7-17(11-21(19)29)16-5-6-16/h7-8,11-14,16H,4-6,9-10H2,1-3H3,(H,33,36)(H2,30,31,32) | Definition date: | 2019-11-14 | Last modified: | 2024-09-27 | Release date: | 2020-03-04 | Identifier: | ~{N}-[3-[6-azanyl-5-[2-[methyl(propanoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoranyl-2-methyl-phenyl]-4-cyclopropyl-2-fluoranyl-benzamide |
|
 | MSO | Name: | SELENOMETHIONINE SELENOXIDE | Formula: | C5 H11 N O3 Se | SMILES: | O=C(O)C(N)CC[Se](=O)C | InChi: | InChI=1S/C5H11NO3Se/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-,10+/m0/s1 | Definition date: | 2000-08-18 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-4-(methylseleninyl)butanoic acid |
|
 | L4R | Name: | Fmoc-(R)-2-(7-octenyl)alanine | Formula: | C11 H21 N O2 | SMILES: | C[C](N)(CCCCCCC=C)C(O)=O | InChi: | InChI=1S/C11H21NO2/c1-3-4-5-6-7-8-9-11(2,12)10(13)14/h3H,1,4-9,12H2,2H3,(H,13,14)/t11-/m1/s1 | Definition date: | 2022-06-16 | Last modified: | 2024-09-27 | Release date: | 2022-07-20 | Identifier: | (2~{R})-2-azanyl-2-methyl-dec-9-enoic acid |
|